Precision BioSciences, Inc.

NASDAQ:DTIL

Biotechnology

Healthcare
$6.91 +1.69%

+$0.11 today

Market cap
$193.04M
Beta
1.28
P/E (TTM)
-1.9
EPS (TTM)
-$3.47
52W Low $3.53High $8.82

Volume 0.27M

Average 0.31M

Returns on capital

Precision BioSciences, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-50.5%

avg -75.5%

ROIC

-35.5%

avg -37.2%

ROA

-30.2%

avg -30.7%

Analysis

ROA is currently the strongest return metric at -30.2% versus its period average of -30.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Michael Amoroso

President, Chief Executive Officer & DirectorUSD 1.16M48243.39K1.90%

John Alexander Kelly

Chief Operating OfficerUSD 717.06K59125.88K0.98%

Dario Scimeca

Chief Legal Officer & SecretaryUSD 659.64K5156.78K0.44%

Jefferson J. Smith

Co-Founder & Chief Research OfficerUSD 640.2K53121.93K0.95%

Naresh Tanna

Chief Financial OfficerUSD 623.58K45——

Cindy Atwell

Chief Development Officer————

Mei Burris

VP of Finance & Chief Accounting Officer—40——

Cassie Gorsuch

Chief Scientific Officer————

Neil Leatherbury

Senior Vice President and Head of Chemistry, Manufacturing & Controls————

Juli Blanche

Chief People Officer————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 10, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

6

$63,214.54

Sells

9

$458,775.31

Net Transaction Value

−$395,560.77

Net selling

Most Active

Scimeca Dario

3 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 10, 26

Scimeca Dario

Direct

Sell$27.5K
Sep 28, 26

Frankel Stanley

Direct

Buy$6K
Sep 25, 26

Brown Melinda

Direct

Buy$7.1K
Sep 25, 26

Germano Geno J

Direct

Buy$16.4K
Feb 18, 26

Kelly John Alexander

Direct

Sell$31.3K
Feb 18, 26

Amoroso Michael

Direct

Sell$78.9K
Feb 18, 26

SMITH J. JEFFERSON

Direct

Sell$18.9K
Feb 18, 26

Scimeca Dario

Direct

Sell$18.9K
Jan 22, 26

Amoroso Michael

Direct

Sell$145.1K
Jan 21, 26

Kelly John Alexander

Direct

Sell$61.3K

1–10 of 15

Summary

Insiders reported 6 buys worth $63,214.54 and 9 sells worth $458,775.31 over the last 12 months. That adds up to net selling of $395,560.77. Scimeca Dario was the most active insider with 3 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+10.9%
+33.1% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at +10.9% over three years. Forward estimates point to Revenue at +33.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Precision BioSciences, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about DTIL's management, answered from reported figures.

Who manages DTIL?

Precision BioSciences, Inc. (DTIL) lists 10 active executives. The top listed executive is Dario Scimeca, Chief Legal Officer & Secretary.

Are DTIL insiders buying or selling?

Recent insider activity shows net selling of $422,709.84.